Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Clopton Clinic
506
mi
from 43215
Jonesboro, AR
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Clopton Clinic
506
mi
from 43215
Jonesboro, AR
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
UCSD Medical Center, Thornton Hospital
1953
mi
from 43215
La Jolla, CA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
UCSD Medical Center, Thornton Hospital
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Gastro Diagnostics
1958
mi
from 43215
Orange, CA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Gastro Diagnostics
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Mayo Clinic, Jacksonville
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Sylvester Comprehensive Cancer Center
992
mi
from 43215
Miami, FL
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Sylvester Comprehensive Cancer Center
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Cirtus Ambulartory Surgery Center
795
mi
from 43215
Orlando, FL
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Cirtus Ambulartory Surgery Center
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Heartland Medical Research, Inc (Administrative Only)
573
mi
from 43215
Clive, IA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Heartland Medical Research, Inc (Administrative Only)
573
mi
from 43215
Clive, IA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Iowa Endoscopy Center (Colonoscopy Only)
573
mi
from 43215
Clive, IA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Iowa Endoscopy Center (Colonoscopy Only)
573
mi
from 43215
Clive, IA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
UMASS Memorial Medical Center
605
mi
from 43215
Worcester, MA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
UMASS Memorial Medical Center
605
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
University of Massachusetts Worcester
604
mi
from 43215
Worcester, MA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
University of Massachusetts Worcester
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Barnes-Jewish Hospital (Investigational Drug Services)
397
mi
from 43215
St. Louis, MO
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Barnes-Jewish Hospital (Investigational Drug Services)
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Center for Advanced Medicine
397
mi
from 43215
St. Louis, MO
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Center for Advanced Medicine
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Life Medi-Research and Management
478
mi
from 43215
Brooklyn, NY
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Life Medi-Research and Management
478
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Nassau Gastroenterology Associates Office Based Surgery
491
mi
from 43215
Great Neck, NY
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Nassau Gastroenterology Associates Office Based Surgery
491
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
East side Endoscopy, LLC (for colonscopy testing only)
442
mi
from 43215
New York, NY
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
East side Endoscopy, LLC (for colonscopy testing only)
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
CTRC Hospital - UNC Memorial Hospital
278
mi
from 43215
Chapel Hill, NC
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
CTRC Hospital - UNC Memorial Hospital
278
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
UNC Hospitals Department of Pharmacy
350
mi
from 43215
Chapel Hill, NC
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
UNC Hospitals Department of Pharmacy
350
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
UNC Hospitals Endoscopy
353
mi
from 43215
Chapel Hill, NC
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
UNC Hospitals Endoscopy
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Hillsborough Campus
343
mi
from 43215
Hillsborough, NC
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Hillsborough Campus
343
mi
from 43215
Hillsborough, NC
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
Thomas Jefferson University Hospital
416
mi
from 43215
Philadelphia, PA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
Thomas Jefferson University Hospital
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
University of Washington Medical Center
2005
mi
from 43215
Seattle, WA
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
University of Washington Medical Center
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
AKH Wien Universitaetsklinik fuer Innere Medizin III
4607
mi
from 43215
Wien,
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
AKH Wien Universitaetsklinik fuer Innere Medizin III
4607
mi
from 43215
Wien,
Click here to add this to my saved trials
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated:  4/13/2017
University of Miami
992
mi
from 43215
Miami, FL
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-00547659 In Subjects With Crohn's Disease (Opera)
Status: Enrolling
Updated: 4/13/2017
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
UCLA Women's Health Clinical Research Unit /ID# 26703
1982
mi
from 43215
Los Angeles, CA
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
UCLA Women's Health Clinical Research Unit /ID# 26703
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Children's Hospital of Orange County /ID# 8162
1959
mi
from 43215
Orange, CA
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Children's Hospital of Orange County /ID# 8162
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
The Children's Hospital /ID# 8163
1154
mi
from 43215
Aurora, CO
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
The Children's Hospital /ID# 8163
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Arnold Palmer Hospital for Children /ID# 21201
796
mi
from 43215
Orlando, FL
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Arnold Palmer Hospital for Children /ID# 21201
796
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Children's Center for Digestive Health Care /ID# 8152
426
mi
from 43215
Atlanta, GA
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Children's Center for Digestive Health Care /ID# 8152
426
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
University of Chicago Medical Center /ID# 13581
270
mi
from 43215
Chicago, IL
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
University of Chicago Medical Center /ID# 13581
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Loyola University Medical Center /ID# 11781
283
mi
from 43215
Maywood, IL
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Loyola University Medical Center /ID# 11781
283
mi
from 43215
Maywood, IL
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Riley Hospital for Children /ID# 8157
167
mi
from 43215
Indianapolis, IN
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Riley Hospital for Children /ID# 8157
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
The Johns Hopkins University Hospital /ID# 8175
345
mi
from 43215
Baltimore, MD
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
The Johns Hopkins University Hospital /ID# 8175
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Mayo Clinic /ID# 8164
559
mi
from 43215
Rochester, MN
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Mayo Clinic /ID# 8164
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Minnesota Gastroenterology, P.A /ID# 8181
622
mi
from 43215
Saint Paul, MN
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Minnesota Gastroenterology, P.A /ID# 8181
622
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Pediatric Gastroenterology and Nutrition Associates /ID# 8126
1759
mi
from 43215
Las Vegas, NV
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Pediatric Gastroenterology and Nutrition Associates /ID# 8126
1759
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Morristown Medical Center /ID# 25839
453
mi
from 43215
Morristown, NJ
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Morristown Medical Center /ID# 25839
453
mi
from 43215
Morristown, NJ
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
University of North Carolina at Chapel Hill /ID# 23723
354
mi
from 43215
Chapel Hill, NC
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
University of North Carolina at Chapel Hill /ID# 23723
354
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Nationwide Childrens Hospital /ID# 8159
2
mi
from 43215
Columbus, OH
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Nationwide Childrens Hospital /ID# 8159
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Vanderbilt Children's Hospital, /ID# 22983
334
mi
from 43215
Nashville, TN
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Vanderbilt Children's Hospital, /ID# 22983
334
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Seattle Children's Hospital /ID# 8166
2004
mi
from 43215
Seattle, WA
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Seattle Children's Hospital /ID# 8166
2004
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Medical College of Wisconsin at Froedtert Memorial Lutheran /ID# 10964
334
mi
from 43215
Milwaukee, WI
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Medical College of Wisconsin at Froedtert Memorial Lutheran /ID# 10964
334
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated:  4/19/2017
Hospital Universitaire des Enfants Reine Fabiola (HUDERF) /ID# 8205
4049
mi
from 43215
Brussels,
Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
A Multi-center, Open-label Study of the Human Anti−TNF Monoclonal Antibody Adalimumab to Evaluate the Efficacy and the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Crohn's Disease Who Have Demonstrated a Clinical Response in the M06-806 Study
Status: Enrolling
Updated: 4/19/2017
Hospital Universitaire des Enfants Reine Fabiola (HUDERF) /ID# 8205
4049
mi
from 43215
Brussels,
Click here to add this to my saved trials
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated:  4/25/2017
Boston Med Ctr
642
mi
from 43215
Boston, MA
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated: 4/25/2017
Boston Med Ctr
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated:  5/4/2017
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated: 5/4/2017
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated:  5/4/2017
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE)
Status: Enrolling
Updated: 5/4/2017
Oregon Health and Science University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated:  5/16/2017
University of Maryland
343
mi
from 43215
Baltimore, MD
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated: 5/16/2017
University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Comprehensive Clinical Research
428
mi
from 43215
Berlin, NJ
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Comprehensive Clinical Research
428
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Stony Brook University Medical Center
549
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated:  5/18/2017
Oklahoma Foundation for Digestive Research
848
mi
from 43215
Oklahoma City, OK
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease, and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Mild to Severe Crohn's Disease
Status: Enrolling
Updated: 5/18/2017
Oklahoma Foundation for Digestive Research
848
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials